Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTHS | AZN | AMGN | GILD | VRTX |
| Company | Pelthos Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 25.98 | 92.51 | 328.09 | 124.17 | 460.44 |
| High | 26.98 | 93.10 | 333.67 | 127.41 | 461.49 |
| Low | 23.96 | 91.94 | 328.07 | 124.00 | 457.04 |
| Latest | 26.98 | 92.14 | 331.49 | 125.19 | 459.21 |
| Change | +0.22 | +0.59 | +0.10 | +1.03 | -1.10 |
| % Change | +0.82% | +0.64% | +0.03% | +0.83% | -0.24% |
| Volume | 30,700 | 3,544,300 | 1,552,900 | 5,712,800 | 768,500 |
| 20-Day Average Volume | 27,545 | 5,751,895 | 3,212,075 | 7,432,970 | 1,475,970 |
| Previous Close | 26.76 | 91.55 | 331.39 | 124.16 | 460.31 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 25.38 | 91.11 | 330.04 | 122.90 | 446.76 |
| 20-Day Raw Stochastic | 61.91% | 60.40% | 56.20% | 70.27% | 88.51% |
| 20-Day Relative Strength | 49.40 | 59.55 | 55.89 | 55.69 | 60.48 |
| Weighted Alpha | +136.41 | +42.05 | +26.64 | +31.74 | +12.91 |
| Today's Opinion | 24% Buy | 100% Buy | 88% Buy | 96% Buy | 72% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 88% Buy | 88% Buy | 72% Buy |
| Last Month's Opinion | 40% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +23.59% since 12/16/25 | +0.86% since 12/16/25 | +1.45% since 12/16/25 | +5.40% since 12/16/25 | +0.93% since 12/16/25 |
| Low | 20.97 on 12/17/25 | 89.85 on 12/17/25 | 321.91 on 12/18/25 | 118.57 on 12/17/25 | 445.41 on 12/18/25 |
| High | 26.98 on 12/23/25 | 93.10 on 12/23/25 | 333.67 on 12/23/25 | 127.41 on 12/23/25 | 461.49 on 12/23/25 |
| 1-Month | |||||
| %Chg | +6.22% since 11/21/25 | +1.25% since 11/21/25 | -1.79% since 11/21/25 | -1.14% since 11/21/25 | +7.60% since 11/21/25 |
| Low | 20.97 on 12/17/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 30.68 on 12/04/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.25 on 11/24/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -20.55% since 09/23/25 | +21.28% since 09/23/25 | +15.58% since 09/23/25 | +9.43% since 09/23/25 | +20.93% since 09/23/25 |
| Low | 20.97 on 12/17/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 37.50 on 11/06/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +130.60% since 06/23/25 | +30.44% since 06/23/25 | +21.67% since 06/23/25 | +17.89% since 06/23/25 | +3.53% since 06/23/25 |
| Low | 11.21 on 06/27/25 | 68.61 on 07/21/25 | 269.01 on 06/24/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 54.29 on 07/07/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 82,600 | 283,937,952 | 178,447,232 | 154,042,848 | 116,789,392 |
| Shares Outstanding, K | 3,087 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -7,960,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 7,410,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -16,240,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 4.05 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -5.30 on 11/13/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/26/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.99 | 14.97 | 15.18 | 29.80 |